Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate Presentation – February 2021 de adocia

Latest Press Releases

2021/02/16Number of shares and voting rights of ADOCIA as of January 31, 2021
2021/01/25Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao

All Press releases

Next events

March 22-25, 2021 BIO-Europe Spring - Europe's largest springtime digital partnering event dedicated to Life science companies

TOP